Pathogenesis of Coronary Atherosclerosis

  • S. David Gertz
  • Adi Kurgan
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 90)

Abstract

In the United States between 1974 and 1977, 52% of all causes of death were attributed to cardiovascular diseases {l}. By 1981 and 1982 this figure declined slightly to 49%. Since 1974 ischemic heart diseases have accounted for approximately 65% of all cardiovascular diseases and were responsible for every third death in the United States during this period. The purported increase in the incidence of ischemic heart disease in civilized communities during the first two thirds of this century has been attributed variously to the decline and/or extinction of infectious disease, to a “less than optimal adaptation to changing patterns of lifestyle,” and to advances in diagnostic techniques. Although the mortality rate for ischemic heart disease in the United States has declined significantly (24%) since 1963 {1–3}, its incidence has not, and this entity remains the cause of more deaths in the United States than any other disease.

Keywords

Migration Aspirin Angiotensin Prostaglandin Choline 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    World Health Statistics Annual. Vol 1: Vital Statistics and Causes of Death. Geneva: World Health Organization, 1977, pp 272–279; 1978, pp 218–225; 1979, pp 134–141; 1980, pp 108–115; 1985, pp 154–165. 750Google Scholar
  2. 2.
    Cooper R, Stamler L, Dyer A, Garside D: The decline in mortality form coronary heart disease, USA, 1968–1975. J Chronic Dis 31: 709–720, 1978.PubMedCrossRefGoogle Scholar
  3. 3.
    Stern MP: The recent decline in ischemic heart disease mortality. Ann Intern Med 91: 630–640.Google Scholar
  4. 4.
    Stein O, Stein Y, Eisenberg S: Radioautographic study of the transport of125 iodine-labeled serum lipoproteins in rat aorta. Z Zellforsch Mikrosk Anat 138: 223–237, 1973.PubMedCrossRefGoogle Scholar
  5. 5.
    Vlodaver Z, Edwards JE: Pathology of coronary atherosclerosis. Prog Cardiovasc Dis 14: 256–274, 1971.PubMedCrossRefGoogle Scholar
  6. 6.
    Wissler RW: Principles of the pathogenesis of atherosclerosis. In: Braunwald E (ed) Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia: WB Saunders, 1980, pp 1221–1245,Google Scholar
  7. 7.
    Wall RT, Harker LA: The endothelium and thrombosis. Ann Rev Med 31: 361–371, 1980.PubMedCrossRefGoogle Scholar
  8. 8.
    Hoak JC, Czervionke RL, Fry GL, Haycraft DL, Brotherton AA: Role of the vascular endothelium. Philos Trans Roy Soc Lond B 294: 331–338, 1981.CrossRefGoogle Scholar
  9. 9.
    Nawroth PP, Stern DM: A pathway of coagulation on endothelial cells. J Cell Biochem 28: 252–264, 1985.CrossRefGoogle Scholar
  10. 10.
    Reidy MA, Schwartz SM: Arterial endothelium - assessment of in vivo injury. Exp Mol Pathol 41: 419–434, 1984.PubMedCrossRefGoogle Scholar
  11. 11.
    Reidy MA: Biology of disease. A reassessment of endothelial injury and arterial lesion formation. Lab Invest 53; 513–520, 1985.PubMedGoogle Scholar
  12. 12.
    Ross R, Klebanoff SJ: The smooth muscle cell. I. In vivo synthesis of connective tissue proteins. J Cell Biol 50: 159, 1971.Google Scholar
  13. 13.
    Wight TN, Ross R: Proteoglycans in primate arteries. II. Synthesis and secretion of glycosamino- glycans by arterial smooth muscle cells in culture. J Cell Biol 67: 675–686, 1975.PubMedCrossRefGoogle Scholar
  14. 14.
    Narayanan S, Sanberg LB, Ross R, Layman D: The smooth muscle cell. III. Elastin synthesis in arterial smooth muscle cell culture. J Cell Biol 68:411 –419, 1976.Google Scholar
  15. 15.
    Campbell GR, Campbell JH: Smooth muscle pheno- typic changes in arterial wall homeostasis: Implications for the pathogenesis of atherosclerosis. Exp Mol Pathol 42: 139–162, 1985.PubMedCrossRefGoogle Scholar
  16. 16.
    Wissler RW: The cellular pathobiology of atherosclerosis in 1983. Adv in Exp Med and Biology 183: 1–16, 1985.Google Scholar
  17. 17.
    Wolinsky H, Glagov S: Comparison of abdominal and thoracic aortic medial structure in mammals: Deviation of man from the usual pattern. Circ Res 25: 677–686, 1969.PubMedGoogle Scholar
  18. 18.
    Ross R, Glomset J A: The pathogenesis of atherosclerosis I. N Engl Med 295: 369–377, 1976.CrossRefGoogle Scholar
  19. 19.
    Ross R, Glomset JA: The pathogenesis of atherosclerosis II. N Engl J Med 295: 420–425, 1976.PubMedCrossRefGoogle Scholar
  20. 20.
    Ross R: The arterial wall and atherosclerosis. Ann Rev Med 30: 1–15, 1979.PubMedCrossRefGoogle Scholar
  21. 21.
    Stemerman MB: Hemostasis, thrombosis and athero- genesis. Atheroscl Rev 6: 105–146, 1979.Google Scholar
  22. 22.
    Oeser J, Fehr R, Brinkmann B: Aortic and coronary atherosclerosis in a Hamburg autopsy series. Virch Arch (Pathol Anat) 384: 131–148, 1979.CrossRefGoogle Scholar
  23. 23.
    Velican C, Velican D: Coronary intimal necrosis occurring as an early stage of atherosclerotic involvement. Atherosclerosis 39: 479–496, 1981.PubMedCrossRefGoogle Scholar
  24. Constantinides P: Atherosclerosis — a general survey and synthesis. Surv Synth Path Res 3: 477–498,Google Scholar
  25. 25.
    Altman RFA, Ramos de Souza AS: Mechanism of progression and regression of atherosclerosis. Wld Rev Nutr Diet 46: 219–251, 1985.Google Scholar
  26. 26.
    Jokinen MP, Clarkson TB, Prichard RW: Animal models in atherosclerosis research. Exp Mol Pathol 42: 1–28, 1985.PubMedCrossRefGoogle Scholar
  27. 27.
    Flaherty JT, Ferrans VJ, Pierce JE, Carew TE, Fry DL: Localizing factors in experimental atherosclerosis. In: Likoff W, Segal BL, Insull W, Mayer JH (eds) Atherosclerosis and Coronary Heart Disease. New York: Grune and Stratton, 1972, pp 40–84.Google Scholar
  28. 28.
    Werb Z, Gordon S: Elastase secretion by stimulated macrophages. J Exp Med 142: 361–377, 1975.PubMedCrossRefGoogle Scholar
  29. 29.
    Mendlowitz M: Arterial calcium metabolism, hypertension and arteriosclerosis. Cardiology 67: 81–89, 1981.PubMedCrossRefGoogle Scholar
  30. 30.
    Fowler S, Shiu H, Haley NJ: Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. Lab Invest 41: 372–378, 1979.PubMedGoogle Scholar
  31. 31.
    Watanabe T, Hirata M, Yoshikawa Y, Nagafuchi Y, Toyoshima H, Watanabe T: Role of macrophages in atherosclerosis: Sequential observations of cholesterol- induced rabbit aortic lesion by the immunoper- oxidase technique using monoclonal antimacrophage antibody. Lab Invest 53: 80–90, 1985.PubMedGoogle Scholar
  32. 32.
    Smith EB, Smith RH: Early changes in the aortic intima. Atheroscl Rev 3: 119–136, 1976.Google Scholar
  33. 33.
    Stein O, Halperin G, Stein Y: Cholesterylester efflux from extracellular and cellular elements of the arterial wall. Model systems in culture with choles- teryl linoleyl ether. Arteriosclerosis 6: 70–78, 1986.PubMedCrossRefGoogle Scholar
  34. 34.
    Fox B, James K, Morgan B, Seed A: Distribution of fatty and fibrous plaques in young human coronary arteries. Atherosclerosis 41: 337–347, 1982.PubMedCrossRefGoogle Scholar
  35. 35.
    Texon M: Hemodynamic basis of atherosclerosis. New York: McGraw-Hill, 1970.Google Scholar
  36. 36.
    Wright HP: Endothelial turnover. Thromb Diath Haemorrh (Suppl) 40: 79–85, 1970.Google Scholar
  37. 37.
    Spaet TH, Gay nor E: Vascular endothelial damage and thrombosis. Adv Cardiol 4: 47–66, 1970.PubMedGoogle Scholar
  38. 38.
    Poole JCP, Sanders AG, Florey HW: The regeneration of aortic endothelium. J Pathol Bacteriol 175: 133–143, 1958.CrossRefGoogle Scholar
  39. 39.
    Baumgartner HR, Spaet TH: Endothelial replace-ment in rabbit arteries. Fed Proc 29: 710, 1970.Google Scholar
  40. 40.
    Spaet TH, Stemerman MB, Lejnecks I: The role of smooth muscle cells in repopulation of rabbit aortic endothelium following balloon catheter injury. Fed Proc 32: 219, 1973.Google Scholar
  41. 41.
    Fishman JA, Ryan GB, Karnovsky MJ: Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the patho-genesis of myointimal thickening. Lab Invest 32: 339–351, 1975.PubMedGoogle Scholar
  42. 42.
    Chiang J, Kowada M, Ames A III, Wright RL, Majno G: Cerebral ischemia. III. Vascular changes. Am J Pathol 52: 455–76, 1968.PubMedGoogle Scholar
  43. 43.
    Gertz SD, Forbes MS, Sunaga T, Kawamura J, Rennels ML, Shimamoto T, Nelson E: Ischemic carotid endothelium: Transmission electron micro-scopic studies. Arch Pathol Lab Med 100: 522–526, 1976.PubMedGoogle Scholar
  44. 44.
    Yu MC, Bakay L, Lee JC: Ultrastructure of the central nervous system after prolonged hypoxia. II. Neuroglia and blood vessels. Acta Neuropathol (Berlin) 22: 235–244, 1972.CrossRefGoogle Scholar
  45. 45.
    Boxen I: Mechanisms of atherogenesis: Endothelial hypoxia proposed as the major initiator. Med Hypoth 18: 297–311, 1985.CrossRefGoogle Scholar
  46. 46.
    Hoff HF: Vascular injury: A review. In: Koller F, Brinkhous KM, Biggs R, Rodman NF, Hinnom S (eds) Vascular Factors and Thrombosis. Stuttgart: FK Schattauer Verlag, 1970, pp 121–136.Google Scholar
  47. 47.
    Gardner DL, Mathews MA: Ultrastructure of the wall of small arteries in early experimental rat hypertension. J Pathol 97: 51–62, 1969PubMedCrossRefGoogle Scholar
  48. 48.
    Kjeldson K, Astrup P, Wanstrup J: Ultrastructural intimai changes in the rabbit aorta after a moderate carbon monoxide exposure. Atherosclerosis 16: 67– 87, 1972.Google Scholar
  49. 49.
    Constantinides P: The important role of endothelial changes in atherogenesis. In: Shimamoto T, Numano F (eds) Atherogenesis II. Amsterdam: Excerpta Medica 1973, pp 51–65.Google Scholar
  50. 50.
    Gertz SD, Kurgan A, Wajnberg RS, Nelson E: Endothelial cell damage and thrombus formation following temporary arterial occlusion: Effects of pretreatment with aspirin or heparin. J Neurosurg 50: 578–586, 1979.PubMedCrossRefGoogle Scholar
  51. 51.
    Harker L, Ross R, Slichter S: Homocystine-induced arteriosclerosis: The role of endothelial injury and platelet response in its genesis. J Clin Invest 58: 731–741, 1976.PubMedCrossRefGoogle Scholar
  52. 52.
    Gay nor E, Bouvier CA, Spaet TH: Vascular lesions: Possible pathogenetic bases of the generalized Schwartzman reaction. Science 170: 986–988, 1970.PubMedCrossRefGoogle Scholar
  53. 53.
    Poston RN: Immunological aspects of atheroma: A review. Roy Soc Med 72: 674–681, 1979.Google Scholar
  54. 54.
    Ross R, Harker L; Hyperlipidemia and athero-sclerosis. Science 193: 1094–1100, 1976.PubMedCrossRefGoogle Scholar
  55. 55.
    Stewart GJ, Ritchie WGM, Lynch PR: Venous endothelial damage produced by massive sticking and emigration of leukocytes. Am J Pathol 74: 507–522, 1974.PubMedGoogle Scholar
  56. 56.
    Marchesi VT: Some electron microscopic observation on interactions between leukocytes, platelets and endothelial cells in acute inflammation. Ann NY Acad Sei 116: 174–488, 1964.Google Scholar
  57. 57.
    Joris I, Majno G: Endothelial changes induced by arterial spasm. Am J Pathol 102: 346–358, 1981.PubMedGoogle Scholar
  58. 58.
    Gertz SD, Uretzky G, Wajnberg RS, Navot N, Gotsman MS: Endothelial cell damage and thrombus formation after partial arterial constriction: Relevance to the role of coronary artery spasm in the pathogenesis of myocardial infarction. Circulation 63: 476–486, 1981.PubMedCrossRefGoogle Scholar
  59. 59.
    Karnosky MJ: Endothelial-vascular smooth muscle cell interactions. Am J Pathol 105: 200–206, 1981.Google Scholar
  60. 60.
    Bratzler RL, Chisolm GM, Colton CK, Smith KA, Lees RS: The distribution of labeled-low-density lipoprotein across the rabbit thoracic aortic in vivo. Atherosclerosis 25: 289–307, 1977.CrossRefGoogle Scholar
  61. 61.
    Majno G, Joris I, Zand T: Atherosclerosis: New horizons. Human Pathol 16: 1–5, 1985.CrossRefGoogle Scholar
  62. 62.
    Ross R, Bowen-Pope DF, Raines EW: Platelet derived growth factor: Its potential roles in wound healing, atherosclerosis,1 neoplasia, and growth and development. Ciba Found Symp 116: 98–112, 1985.PubMedGoogle Scholar
  63. 63.
    Gajdusek C, Schwartz S, Di Corleto P, Ross R: Endothelial cell derived mitogenic activity. Fed Proc 38: 1075, 1979.Google Scholar
  64. 64.
    Leibovich S, Ross R: A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol 84: 501–514, 1976.PubMedGoogle Scholar
  65. 65.
    Leibowitz JO: The history of coronary heart disease. Berkeley: University of California, 1970.Google Scholar
  66. 66.
    Von Rokitansky C: A Manual of Pathological Anatomy (trans GE Day). London: New Sydenham Society, 1852.Google Scholar
  67. 67.
    Duguid JB: Thrombosis as a factor in the patho-genesis of aortic atherosclerosis. J Pathol Bacteriol 60: 57–61, 1948.PubMedCrossRefGoogle Scholar
  68. 68.
    Duguid JB: Mural thrombosis in arteries. Br Med Bull 2: 36–38, 1955.Google Scholar
  69. 69.
    Virchow R: Phlogose und thrombose im gefä- sssystem. In: Gesammelte Abhandlungen zur Wissenschaftlichen Medizin. Frankfurt-am-Main: Meidinger, 1856.Google Scholar
  70. 70.
    Virchow R. Gesammelte abhandlungen zur wis-senschaftlichen medizin: Phlogose und thrombose im gefasssystem. Berlin: Max Hirsch, 1862.Google Scholar
  71. 71.
    Anitschkow NN: Uber Veränderungen der kan- inchenaorta bei experimentelle cholesterinsteatose. Beitr Pathol Anat 56: 379–404, 1913.Google Scholar
  72. 72.
    Anitschkow NN: A history of experimentation on arterial atherosclerosis in animals. In: Blumenthal HT (ed) Cowdrys arteriosclerosis, 2nd ed. Spring-field, IL: CC Thomas, 1967, pp 21–44.Google Scholar
  73. 73.
    Miller NE: Plasma lipoproteins, lipid transport, and atherosclerosis: Recent developments. J Clin Pathol 32: 639–650, 1979.PubMedCrossRefGoogle Scholar
  74. 74.
    Asmal AC, Leary WP: Classification of hyper- lipidaemias: A time of review? South Afr Med J 50: 915–918, 1975.Google Scholar
  75. 75.
    Brown MS, Goldstein JL: The hyperlipoproteinemias and other disorders of lipid metabolism. In: Issel- bacher KJ, Adams RD, Braunwald E, Petersdorf RG, Wilson JD (eds) Harrison’s Principles of Internal Medicine. London: McGraw-Hill, 1980, pp 507–518.Google Scholar
  76. 76.
    Wolinsky H: A proposal linking clearance of circulating lipoproteins to tissue metabolic activity as a basis for understanding atherogenesis. Circ Res 47: 301–311, 1980.PubMedGoogle Scholar
  77. 77.
    Haimovici H: Atherogenesis: Recent biological concepts and clinical implications. Am J Surg 134: 174–178, 1977.PubMedCrossRefGoogle Scholar
  78. 78.
    Dolder MA, Oliver MF: Myocardial infarction in young men: Study of risk factors in nine countries. Br Heart J 37: 493–503, 1975.PubMedCrossRefGoogle Scholar
  79. 79.
    Hoff HF, Heideman CL, Jackson RL, Bayardo RJ, Kim H, Gotto AM Jr: Localization patterns of plasma apolipoproteins in human atherosclerotic lesions. Circ Res 37: 72–79, 1975.PubMedGoogle Scholar
  80. 80.
    Onitini AC, Lewis B, Bentall H, Jamieson C, Wisheart J, Faris I: Lipoprotein cocentrations in serum and in biopsy samples of arterial intima: A quantitative comparison. Atherosclerosis 23: 513– 519, 1976.Google Scholar
  81. 81.
    Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ: HDL, cholesterol and other lipids in coronary heart disease: The co-operative lipoprotein phenotyping study. Circulation 55: 767–72, 1977.PubMedGoogle Scholar
  82. 82.
    Fredrickson DS, Goldstein JL, Brown MS: The familial hyperlipoproteinemias, in: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) The Metabolic basis of Inherited disease, 4th ed. New York: McGraw-Hill, 1978, pp 604–655.Google Scholar
  83. 83.
    Stamler J: Life styles, major risk factors, proof and public policy. Circulation 58: 3–19, 1978.PubMedGoogle Scholar
  84. 84.
    Scott RF, Daoud AS, Florentin RA: Animal models in atherosclerosis. In: Wissler RW, Geer JC (eds) The Pathogenesis of Atherosclerosis. Baltimore: Williams and Wilkins, 1972, pp 120–146.Google Scholar
  85. 85.
    Hoff HF, Heideman CL, Gaubatz JW, Titus JC, Gotto AM Jr: Quantitaion of apo-B in human aortic fatty streaks: A comparison with grossly normal intima and fibrous plaques. Atherosclerosis 30: 263–272, 1978.PubMedCrossRefGoogle Scholar
  86. 86.
    Zilversmit DB: Atherogenesis: A postprandial phenomenon. Circulation 60: 473–485, 1979.PubMedGoogle Scholar
  87. 87.
    Steinberg D: Underlying mechanisms in atherosclerosis. J Pathol 133: 75–87, 1981.PubMedCrossRefGoogle Scholar
  88. 88.
    Miller GJ: High density lipoproteins and atherosclerosis. Ann Rev Med 31: 97–108, 1980.PubMedCrossRefGoogle Scholar
  89. 89.
    Stehbens WE: The role of lipid in the pathogenesis of athrosclerosis. Lancet 1: 724–726, 1975.PubMedCrossRefGoogle Scholar
  90. 90.
    Thoma R: Uber die abhangigkeit dr hindegeweb- sneubildung in der arterienintima von den mechanischen Bendingungen des blutumlaufes. Virchows Arch (Pathol Anat) 93: 443–505, 1883.Google Scholar
  91. 91.
    Blumenthal HT, Lansing AL, Wheeler PA: Calcification of the media of the human aorta and its relation to intimal arteriosclerosis, aging and disease. Am J Pathol 20: 665–679, 1944.PubMedGoogle Scholar
  92. 92.
    Walton KW: Pathogenetic mechanisms in atherosclerosis. Am J Cardiol 35: 542–558, 1975.PubMedCrossRefGoogle Scholar
  93. 93.
    Martin GM, Sprague CA: Symposium on in vi tor studies related to atherogenesis: Life histories of hyperplastoid cell lines from aorta and skin. Exp Mol Pathol 18: 125–141, 1973.PubMedCrossRefGoogle Scholar
  94. 94.
    Benditt EP, Benditt JM: Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sei USA 70: 1753–1756, 1973.CrossRefGoogle Scholar
  95. Benditt EP: The monoclonal theory of atherogenesis. Atherogenesis. Atheroscl Rev 3: 77–85, 1978,Google Scholar
  96. 96.
    Failkow PJ: The origin and development of human tumors studied with cell markers. N Engl J Med 291: 26–35, 1974.CrossRefGoogle Scholar
  97. 97.
    Cerilli J, Brasile L, Karmody A: Role of the vascular endothelial cell antigen system in the etiology of atherosclerosis. Ann Surg 202: 329–334, 1985.PubMedCrossRefGoogle Scholar
  98. 98.
    Kosek JC, Bieber C, Lower RR: Heart graft arteriosclerosis. Transplant Proc 3: 512–514, 1971.PubMedGoogle Scholar
  99. 99.
    Svendsen UG: The importance of thymus in the pathogenesis of the chronic phase of hypertension in mice following partial infarction of the kidney. Acta Pathol Microbiol Scand A 85: 539–547, 1977.PubMedGoogle Scholar
  100. 100.
    Cochrane CG, Koffler D: Immune complex disease in experimental animals and man. Adv Immunol 16:Google Scholar
  101. 101.
    264, 1973.Google Scholar
  102. 102.
    Kniker WT, Cochrane CG: Pathogenetic factors in vascular lesions of experimental serum sickness. J Exp Med 122: 83–97, 1965.PubMedCrossRefGoogle Scholar
  103. 103.
    Minick CR, Murphy GE, Campbell WG: Experimental induction of atheroarteriosclerosis by the synergy of allergic damage to arteries and a lipid rich diet. J Exp Med 124: 635–652, 1966.PubMedCrossRefGoogle Scholar
  104. 104.
    Howard AN, Patelski J, Bowyer DE, Gresham GA: Atherosclerosis induced in hypercholesterolaemic baboons by immunological injury and the effects of intravenous polyunsaturated phosphatidyl choline. Atherosclerosis 14: 17–29, 1971.PubMedCrossRefGoogle Scholar
  105. 105.
    Pfueller SL, Luscher EF: The effects of aggregated immunoglobulins on human blood platelets in relation to their complement fixing abilities. J Immunol 109: 517–533, 1972.PubMedGoogle Scholar
  106. 106.
    Hart MN, Tasseil SK, Sadwasser KL, Schelper RL, Moore SA: Autoimmune vasculitis resulting from in vitro immunization of lymphocytes to smooth muscle. Am J Pathol 119: 448–455, 1985.PubMedGoogle Scholar
  107. 107.
    Rodnan GP, Schumacher HR, Zvaifler NJ: Primer on the Rheumatic Diseases, 8th ed. Atlanta, Georgia! Arthritis Foundation, 1983, pp 60–77.Google Scholar
  108. 108.
    Liang GC, Simkin PA, MannikM; Immunoglubulins in temporal arteritis: An immunofluorescence study. Ann Intern Med 81: 19–24, 1974.PubMedGoogle Scholar
  109. 109.
    Gertz SD, Kurgan A, Eisenberg D: Aneurysm of the rabbit common carotid artery induced by per- arterial application of calcium chloride in vivo. J Clin Invest 81: 649–656, 1988.PubMedCrossRefGoogle Scholar
  110. 110.
    Beaumont JL, Beaumont V: Autoimmune hyper- lipidemia. Atherosclerosis 26: 405–418, 1977.PubMedCrossRefGoogle Scholar
  111. 111.
    Grotendorst GR, Seppa HEJ, Kleinman HK, Martin GR: Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc Natl Acad Sci USA 78: 3669–3672, 1981.PubMedCrossRefGoogle Scholar
  112. 112.
    Moore S: Pathogenesis of atherosclerosis. Metabolism (Suppl 1 ) 34: 13–16, 1985.Google Scholar
  113. 113.
    Guy ton JR, Karnovsky MJ: Smooth muscle cell proliferation in the occluded rat carotid artery: Lack of requirement for luninal platelets. Am J Pathol 94: 585–596, 1979.PubMedGoogle Scholar
  114. 114.
    Moore S, Freidman RJ, Singal DP, Gauldie J, Blajchman MA, Roberts RS: Inhibition of injury induced thromboatherosclerotic lesions by antiplatelet serum in rabbits. Thromb Haemost 35: 70–81, 1976.PubMedGoogle Scholar
  115. 115.
    Fuster V, Bowie EJW, Lewis JC, Fass DN, Owen CA Jr, Brown AL: Resistance to arteriosclerosis in pigs with von Willebrand’s disease. J Clin Invest 61: 722–730, 1978.PubMedCrossRefGoogle Scholar
  116. 116.
    Griggs TR, Reddick RL, Sultzer D, Brinkhous KM: Susceptibility of atherosclerosis in aortas and. coronary arteries of swine with von Willebrand’s disease. Am J Pathol 102: 137–145, 1981.PubMedGoogle Scholar
  117. 117.
    Moncada S, Gryglewski R, Bunting SL, Vane JR: An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 163: 663–665, 1976.CrossRefGoogle Scholar
  118. 118.
    Mustard JF, Kinlough-Rathbone RL, Packham MA: Prostaglandins and platelets. Ann Rev Med 31: 89–96, 1980PubMedCrossRefGoogle Scholar
  119. 119.
    Weiss HJ: Antiplatelet therapy. N Engl J Med 298: 1344–1347, 1978.PubMedCrossRefGoogle Scholar
  120. 120.
    Weiss HJ: Antiplatelet therapy. N Engl J Med 298: 1403–1406, 1978.PubMedCrossRefGoogle Scholar
  121. 121.
    Grunwald J, Haudenschild CC: The influence of antiplatelet drugs on injury-stimulated migration of cultured smooth muscle cells. Artery 12: 324–336, 1985.PubMedGoogle Scholar
  122. 122.
    Plate G, Stanson AW, Hollier LH, Dewanjee MK: Drug effects on platelet deposition after endothelial injury of the rabbit aorta. J Surg Res 39: 258–266, 1985.PubMedCrossRefGoogle Scholar
  123. 123.
    Parmley WW, Blumlein S, Sievers R: Modification of experimental atherosclerosis by calcium-channel blockers. Am J Cardiol 55: 165B–171B, 1985.PubMedCrossRefGoogle Scholar
  124. 124.
    Carvalho ACA, Colman RW, Lees RS: Platelet function in hyperlipoproteinemia N Engl J Med 290: 434–438, 1974.Google Scholar
  125. 125.
    Yamazaki H, Sano T, Kobayashi I, Takahashi T, Shimamoto T: Enhancement of ADP-induced platelet aggregation by adrenaline and cholesterol in vivo and its prevention. In: Shimamoto T, Numano F (eds) Atherogenesis II. Amsterdam: Experpta Medica, 1973, pp 177–194.Google Scholar
  126. 126.
    Iacono JM, Binder RA, Marshall MW, Shoene NW, Jencks JA, Mackin JF: Decreased susceptibility to thrombin and collagen platelet aggregation in man fed low fat diet. Haemostasis 3: 306–318, 1975.Google Scholar
  127. 127.
    Moore S: Endothelial injury and atherosclerosis. Exp Mol Pathol 31: 182–190, 1979.PubMedCrossRefGoogle Scholar
  128. 128.
    Hirsch EZ, Robertson AL: Selective acute arterial endothelial injury and repair. I. Methodology and surface characteristics. Atherosclerosis 28: 271–287, 1977.PubMedCrossRefGoogle Scholar
  129. 129.
    Reidy MA, Schwartz SM: Endothelial regenerating. III. Time course of intimal changes after small defined injury to rat aortic endothelium. Lab Invest 44: 301–308, 1981.PubMedGoogle Scholar
  130. 130.
    Fry DL: Hemodynamic forces in atherogenesis. In: Scheinberg P (ed) Cerebrovascular Diseases. New York: Raven Press, 1976, pp 77–95.Google Scholar
  131. 131.
    Caplan BA, Schwartz CJ: Increased endothelial cell turn-over in areas of in vivo Evans blue up-take in the pig aorta. Atherosclerosis 17: 401–417, 1973PubMedCrossRefGoogle Scholar
  132. 132.
    Langille BL, Adamson SL: Relationship between blood flow direction and endothelial cell orientation at arterial branch sites in rabbits and mice. Circ Res 48: 481–488, 1981.PubMedGoogle Scholar
  133. 133.
    Nelson E, Gertz SD, Forbes MS, Rennels ML, Heald FD, Khan MA, Farber TM, Miller E, Husain MM, Earl FL: Endothelial lesions in the aorta of egg yolk- fed miniature swine: A study by scanning and transmission electron microscopy. Exp Mol Pathol 25: 208–220, 1976.PubMedCrossRefGoogle Scholar
  134. 134.
    Lewis JC, Kottke BA: Endothelial damage and thrombocyte adhesion in pigeon atherosclerosis Science 196: 1007–1009, 1977.Google Scholar
  135. 135.
    Geissinger HD, Mustard JF, Rowsell HC: The occurrence of microthrombi on the aortic endothelium of swine. Can Med Assoc J 87: 405–408, 1962.PubMedGoogle Scholar
  136. 136.
    Gerrity RG, Naito Hk, Richardson M, Schwartz CJ: Dietary induced atherogenesis in swine: Morphology of the intima in prelesion stage. Am J Pathol 95: 775–786, 1979.PubMedGoogle Scholar
  137. 137.
    Fry Dl: Acute vascular endothelial changes associated with increased blood velocity gradients. Circ Res 22: 165–197, 1968.PubMedGoogle Scholar
  138. 138.
    Ku DN, Giddens DP, Zarins CK, Glagov S: Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low and oscillating shear stress. Arteriosclerosis 5: 293–302, 1985.PubMedCrossRefGoogle Scholar
  139. 139.
    Veress B, Balint A, Kocze A, Nasy Z, Jellinek H: Increasing aortic permeability by atherogenic diet. Atherosclerosis 11: 369–371, 1970.PubMedCrossRefGoogle Scholar
  140. Bretherton KN, Day AJ, Skinner SL: Effect of hypertension on the entry of 125I–754Google Scholar
  141. 141.
    Schwartz SM: Hypertension, endothelial injury and atherosclerosis. CardiovascMed2: 991–1002, 1977.Google Scholar
  142. 142.
    Wexler BC, lams SG, Judd JT: Arterial lesions in repeatedly bred spontaneously hypertensive rats. Cirs Res 38: 494–501, 1976.Google Scholar
  143. 143.
    Haudenschild CC, Prescott MF, Chobanian AV: Effects of hypertension and its reversal on aortic intima lesions of rat. Hypertension 2: 33–44, 1980.PubMedGoogle Scholar
  144. 144.
    Giacomelli F, Weiner J, Spiro D: The cellular pathology of experimental hypertension. V. Increased permeability of cerebral arterial vessels. Am J Pathol 59: 133–160, 1970.PubMedGoogle Scholar
  145. 145.
    Huttner I, Boutet M, More RH: Studies on protein passage through arterial endothelium. III. Effect of blood pressure levels on the passage of fine structural protein tracers through rat arterial endothelium. Lab Invest 29: 536–546, 1973.PubMedGoogle Scholar
  146. 146.
    Bevan RD: An autoradiographic and pathologica study of cellular proliferation in rabbit arteries cor-related with an increase in arterial pressure. Blood Vessels 13: 100–128, 1976.PubMedGoogle Scholar
  147. 147.
    Fry DL: Steady-state macromolecular transport across a multilayered arterial wall. Math Model 6: 353– 368, 1985.Google Scholar
  148. 148.
    Spence JD: Hemodynamic effects of antihypertensive drugs. Possible implications for the prevention of atherosclerosis. Hypertension (Suppl III) 6: III— 163—III—168, 1984.Google Scholar
  149. 149.
    Dhurandhar RW, Watt DL, Silver MD, Trimble AS, Adelman AG: Prinzmetal’s variant form of angina with arteriographic evidence of coronary spasm. Am J Cardiol 30: 902–937, 1976.CrossRefGoogle Scholar
  150. 150.
    Chahine RA, Luchi RJ: Coronary arterial spasm: Culprit or bystander? Am J Cardiol 37: 936–937, 1976.PubMedCrossRefGoogle Scholar
  151. 151.
    Meller J, Pichard A, Dack S: Coronary arterial spasm in Prinzmetal’s variant angina: A proved hypothesis. Am J Cardiol 37: 938–940, 1976.PubMedCrossRefGoogle Scholar
  152. 152.
    Maseri A, l’Abbate A, Baroldi G, Chierchia S, Mar- zilli M, Ballestra AM, Severi S, Parodi O, Biagini A, Distante A, Pesola A: Coronary vasospasm as a possible cause of myocardial infarction. N Engl J Med 299: 1271–1277, 1978.PubMedCrossRefGoogle Scholar
  153. 153.
    Braunwald E: Coronary artery spasm as a cause of myocardial ischemia. J Lab Clin Med 97: 299–312, 1981.PubMedGoogle Scholar
  154. 154.
    Hellstrom HR: The injury-spasm and vascular auto- regulatory hypothesis of ischemic disease. Am J Cardiol 49: 802–810, 1982.PubMedCrossRefGoogle Scholar
  155. 155.
    Epstein SE, Cannon RO, Watson RM, Leon MB, Bonow RO, Rosing DR: Dynamic coronary obstruc-tion as a cause of angina pectoris: Implications regarding therapy. Am J Cardiol 55: 61B–68B, 1985.PubMedCrossRefGoogle Scholar
  156. 156.
    Conti, CR: Myocardial infarction: Thoughts about pathogenesis and the role of coronary artery spasm. Am Heart J 110: 187–193, 1985.PubMedCrossRefGoogle Scholar
  157. 157.
    Maseri A, Chierchia S, Koski JC: Mixed angina pectoris. Am J Cardiol 56: 30E–33E, 1985.PubMedCrossRefGoogle Scholar
  158. 158.
    Folts JD, Crowell EB, Rowe GG: Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 54: 365–370, 1976.PubMedGoogle Scholar
  159. 159.
    Turitto VT, Baumgartner HR: Platelet interaction with subendothelium in flowing rabbit blood: Effect of blood shear rate. Microvasc Res 17: 38–54, 1979.PubMedCrossRefGoogle Scholar
  160. 160.
    Gutstein WH, Lataillade JN, Lewis L: Role of vaso-constriction in experimental artriosclerosis. Circ Res 10: 925–932, 1962.PubMedGoogle Scholar
  161. 161.
    Betz E, Schlote W: Responses of vessel walls to chronically applied electrical stimuli. Basic Res Cardiol 74: 10–20, 1979.PubMedCrossRefGoogle Scholar
  162. 162.
    Lown B, De Silva RA: Is coronary arterial spasm a risk factor for coronary atherosclerosis? Am J Cardiol 45: 901–903, 1980.PubMedCrossRefGoogle Scholar
  163. 163.
    Marzilli M, Goldstein S, Trivella MG, Palumbo C, Maseri A: Some clinical considerations regarding the relation of coronary vasospasm to coronary athero-sclerosis: A hypothetical pathogenesis. Am J Cardiol 45: 882–886, 1980.PubMedCrossRefGoogle Scholar
  164. 164.
    Dalen JE, Ochene IS, Alpert JS: Coronary spasm, coronary thrombosis and myocardial infarction: A hypothesis concerning the pathopysiology of acute myocardial infarction. Am Heart J 104: 1119–1124, 1982.PubMedCrossRefGoogle Scholar
  165. 165.
    Gutstein WH: Coronary spasm and coronary athe-rosclerosis. Am J Cardiol 48: 389–390, 1981.PubMedCrossRefGoogle Scholar
  166. 166.
    Luchi RJ, Chahine RA: Coronary artery spasm, cor-onary artery thrombosis, and myocardiol infarction. Ann Intern Med 95: 502–505, 1981.PubMedGoogle Scholar
  167. 167.
    Braunwald E: A symposium: Experimental and clinical aspects of coronary vasoconstriction. Am J Cardiol 56: 1E–29E, 1985.CrossRefGoogle Scholar
  168. 168.
    Hopkins PN, Williams RR: A survery of 246 sug-gested coronary risk factors. Atherosclerosis 40: 1–52, 1981.PubMedCrossRefGoogle Scholar
  169. 169.
    Roberts WC: Relative importance of lipids and thrombus in the genesis of coronary atherosclerosis. In: Maserli A, Sobel BE, Chierchia S (eds) Hammer-smith cardiology workshop series, Vol 3. Raven Press, New York, pp. 35–38, 1987.d low density lipoprotein into the aortic intima in normal-fed rabbits. Atherosclerosis 24: 99–106, 1976.Google Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • S. David Gertz
  • Adi Kurgan

There are no affiliations available

Personalised recommendations